Ensysce Biosciences Inc. Receives Notice Of Allowance For U.S. Patent For Delivery Of siRNA
3/7/2014 8:51:24 AM
HOUSTON--(BUSINESS WIRE)--Ensysce Biosciences Inc. announced today that the U.S. Patent Office has issued a Notice of Allowance for U.S. Patent Application No. 13/175,314: SINGLE-WALLED CARBON NANOTUBE/SIRNA COMPLEXES AND METHODS RELATED THERETO. The application has claims covering methods of delivering single walled carbon nanotube (SWCNT) complexes with siRNA for therapeutic applications.
Help employers find you! Check out all the jobs and post your resume.
comments powered by